{"DataElement":{"publicId":"2554674","version":"3","preferredName":"Patient Death Reason","preferredDefinition":"Text terms to capture the cause of death for a patient.","longName":"PT_DEATH_RSN","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"2013984","version":"1","preferredName":"Patient Death","preferredDefinition":"information relating to the death of a patient or member of patient's family","longName":"PT_DEATH","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2177068","version":"1","preferredName":"Patient","preferredDefinition":"A person who requires medical care.","longName":"Patient","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Patient","conceptCode":"C16960","definition":"A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"ACAAECCE-7AB6-657B-E034-0003BA0B1A09","latestVersionIndicator":"Yes","beginDate":"2002-10-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-29","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2177610","version":"1","preferredName":"Death","preferredDefinition":"The absence of life or state of being dead.","longName":"Death","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Dead","conceptCode":"C28554","definition":"The cessation of life.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE29A78C-51BA-3A05-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-10-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-29","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008554","version":"1","preferredName":"Treatment/Off-treatment Reasons","preferredDefinition":"justification for or explanation of the administration or cessation of therapy.","longName":"TX_OTX_RSNS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2C9BE32-8BDB-649C-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CB42E9-2461-651B-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2554672","version":"2.1","preferredName":"Death Reason","preferredDefinition":"Text terms to capture the cause of death for a patient.","longName":"DEATH_RSN","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Breast cancer","valueDescription":"Breast cancer","ValueMeaning":{"publicId":"2570141","version":"1","preferredName":"Breast cancer","longName":"2570141","preferredDefinition":"A carcinoma arising from the breast, most commonly the terminal ductal-lobular unit. It is the most common malignant tumor in females. Risk factors include country of birth, family history, menstrual and reproductive history, fibrocystic disease and epithelial hyperplasia, exogenous estrogens, contraceptive agents, and ionizing radiation. The vast majority of breast carcinomas are adenocarcinomas (ductal or lobular). Breast carcinoma spreads by direct invasion, by the lymphatic route, and by the blood vessel route. The most common site of lymph node involvement is the axilla.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Carcinoma","conceptCode":"C4872","definition":"A carcinoma arising from the breast, most commonly the terminal ductal-lobular unit. It is the most common malignant tumor in females. Risk factors include country of birth, family history, menstrual and reproductive history, fibrocystic disease and epithelial hyperplasia, exogenous estrogens, contraceptive agents, and ionizing radiation. The vast majority of breast carcinomas are adenocarcinomas (ductal or lobular). Breast carcinoma spreads by direct invasion, by the lymphatic route, and by the blood vessel route. The most common site of lymph node involvement is the axilla.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DF0A-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-04-09","endDate":null,"createdBy":"SBR","dateCreated":"2004-06-21","modifiedBy":"LUY","dateModified":"2015-02-03","changeDescription":"Concept annotation added for UPitt/TCGA.  Ylu, 02/03/2015.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"293DFDC2-FFC5-E19D-E050-BB89AD434F37","beginDate":"2002-02-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-01-13","modifiedBy":"ONEDATA","dateModified":"2016-01-13","deletedIndicator":"No"},{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"2575365","version":"1","preferredName":"Unknown","longName":"2575365","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F372-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-15","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"MMADDINENI","dateModified":"2024-01-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"293DFDC2-FFCF-E19D-E050-BB89AD434F37","beginDate":"2002-02-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-01-13","modifiedBy":"ONEDATA","dateModified":"2016-01-13","deletedIndicator":"No"},{"value":"Other malignancy","valueDescription":"Other Malignancy","ValueMeaning":{"publicId":"2581287","version":"1","preferredName":"Other Malignancy","longName":"2581287","preferredDefinition":"Different than the one(s) previously specified or mentioned.: A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0A94-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-18","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-10-18","modifiedBy":"LUY","dateModified":"2015-02-03","changeDescription":"Concept annotation added for UPitt/TCGA.  Ylu, 02/03/2015.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"293DFDC2-FFD9-E19D-E050-BB89AD434F37","beginDate":"2006-12-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-01-13","modifiedBy":"ONEDATA","dateModified":"2016-01-13","deletedIndicator":"No"},{"value":"Toxicity of protocol treatment","valueDescription":"Toxicity of protocol treatment","ValueMeaning":{"publicId":"2582501","version":"1","preferredName":"Toxicity of protocol treatment","longName":"2582501","preferredDefinition":"A medical product, practice, or application that is tested in a clinical trial.: The finding of bodily harm due to the poisonous effects of something.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Protocol Agent","conceptCode":"C41161","definition":"A medical product, practice, or application that is tested in a clinical trial.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Toxicity","conceptCode":"C27990","definition":"The finding of bodily harm due to the poisonous effects of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0F52-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-12-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-15","modifiedBy":"LUY","dateModified":"2015-02-03","changeDescription":"Concept annotation added for UPitt/TCGA.  Ylu, 02/03/2015.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"293DFDC2-FFE3-E19D-E050-BB89AD434F37","beginDate":"2006-12-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-01-13","modifiedBy":"ONEDATA","dateModified":"2016-01-13","deletedIndicator":"No"},{"value":"Toxicity of non-protocol treatment","valueDescription":"Toxicity of non-protocol treatment","ValueMeaning":{"publicId":"2582502","version":"1","preferredName":"Toxicity of non-protocol treatment","longName":"2582502","preferredDefinition":"Treatment not specified in a protocol.: An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect.: The finding of bodily harm due to the poisonous effects of something.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Non-Protocol","conceptCode":"C25590","definition":"Treatment not specified in a protocol.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Agent","conceptCode":"C1708","definition":"An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Toxicity","conceptCode":"C27990","definition":"The finding of bodily harm due to the poisonous effects of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0F53-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-12-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-15","modifiedBy":"LUY","dateModified":"2015-02-03","changeDescription":"Concept added for UPitt/TCGA.  Ylu, 02/03/2015.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"293DFDC2-FFED-E19D-E050-BB89AD434F37","beginDate":"2006-12-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-01-13","modifiedBy":"ONEDATA","dateModified":"2016-01-13","deletedIndicator":"No"},{"value":"Other, non-malignant disease","valueDescription":"Other, non-malignant disease","ValueMeaning":{"publicId":"2582503","version":"1","preferredName":"Other, non-malignant disease","longName":"2582503","preferredDefinition":"Different than the one(s) previously specified or mentioned.: For neoplasms, a neoplastic process that, at the time of the pathologic diagnosis, does not show evidence of tissue infiltration and may or may not show evidence of atypical morphologic features (e.g., cellular atypia, formation of complex structures, cellular pseudostratification, and increased mitotic activity).  This term encompasses benign neoplastic processes, neoplastic processes with dysplastic features, and borderline processes.  The former do not metastasize and the latter two are associated with a future risk of stromal invasion and metastasis. For other conditions, a process that is not seriously resistant to treatment or dangerous to health.: Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Non-Malignant","conceptCode":"C25588","definition":"For neoplasms, a neoplastic process that, at the time of the pathologic diagnosis, does not show evidence of tissue infiltration and may or may not show evidence of atypical morphologic features (e.g., cellular atypia, formation of complex structures, cellular pseudostratification, and increased mitotic activity).  This term encompasses benign neoplastic processes, neoplastic processes with dysplastic features, and borderline processes.  The former do not metastasize and the latter two are associated with a future risk of stromal invasion and metastasis. For other conditions, a process that is not seriously resistant to treatment or dangerous to health.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0F54-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-12-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-15","modifiedBy":"LUY","dateModified":"2015-02-03","changeDescription":"Concept annotation added for UPitt/TCGA.  Ylu, 02/03/2015.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"293DFDC2-FFF7-E19D-E050-BB89AD434F37","beginDate":"2006-12-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-01-13","modifiedBy":"ONEDATA","dateModified":"2016-01-13","deletedIndicator":"No"},{"value":"Other, specify","valueDescription":"Other specify","ValueMeaning":{"publicId":"2570538","version":"1","preferredName":"Other specify","longName":"2570538","preferredDefinition":"Be specific about something; define clearly.: Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Specify","conceptCode":"C25685","definition":"Be specific about something; define clearly.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E097-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-06-21","endDate":null,"createdBy":"SBR","dateCreated":"2004-06-21","modifiedBy":"CLOHNES","dateModified":"2023-11-17","changeDescription":"Associated concept to VM for TCGA. mc 11/9/12 - reversed concept order to match the semantics of this phrase which is \"other\" with \"specify\" as a qualifier/modifier - DW 12-30-2015","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"293DFDC3-0001-E19D-E050-BB89AD434F37","beginDate":"2006-12-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-01-13","modifiedBy":"ONEDATA","dateModified":"2016-01-13","deletedIndicator":"No"},{"value":"Cervical Cancer","valueDescription":"Cervical Carcinoma","ValueMeaning":{"publicId":"3125029","version":"1","preferredName":"Cervical Carcinoma","longName":"3125029","preferredDefinition":"Cervical carcinoma may arise from either the exocervical squamous epithelium or the endocervical glandular epithelium.  The major histologic types of cervical carcinoma are: squamous carcinoma, adenocarcinoma, adenosquamous carcinoma, adenoid cystic carcinoma and undifferentiated carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cervical Carcinoma","conceptCode":"C9039","definition":"A carcinoma arising from either the exocervical squamous epithelium or the endocervical glandular epithelium. The major histologic types of cervical carcinoma are squamous cell carcinoma and adenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8C8C84BA-75CF-B840-E040-BB89AD4308AA","latestVersionIndicator":"Yes","beginDate":"2010-07-29","endDate":null,"createdBy":"WHITES","dateCreated":"2010-07-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"293DFDC3-000B-E19D-E050-BB89AD434F37","beginDate":"2010-10-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-01-13","modifiedBy":"ONEDATA","dateModified":"2016-01-13","deletedIndicator":"No"},{"value":"Stomach Cancer","valueDescription":"Gastric Neoplasm","ValueMeaning":{"publicId":"2593172","version":"1","preferredName":"Gastric Neoplasm","longName":"2593172","preferredDefinition":"Cancerous or non-cancerous tumors of the stomach","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastric Neoplasm","conceptCode":"C3387","definition":"A benign or malignant neoplasm involving the stomach.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"28701A35-65CB-579B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-02-01","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-02-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"293DFDC3-0015-E19D-E050-BB89AD434F37","beginDate":"2011-03-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-01-13","modifiedBy":"ONEDATA","dateModified":"2016-01-13","deletedIndicator":"No"},{"value":"Prostate Cancer","valueDescription":"Prostate Carcinoma","ValueMeaning":{"publicId":"2596646","version":"1","preferredName":"Prostate Carcinoma","longName":"2596646","preferredDefinition":"Prostate carcinoma is one of the most common malignant tumors afflicting men.  The majority of carcinomas arise in the peripheral zone and a minority occur in the central or the transitional zone of the prostate gland.  Grossly, prostatic carcinomas appear as ill-defined yellow areas of discoloration in the prostate gland lobes.  Adenocarcinomas represent the overwhelming majority of prostatic carcinomas.  Prostatic-specific antigen (PSA) serum test is widely used as a screening test for the early detection of prostatic carcinoma.  Treatment options include radical prostatectomy, radiation therapy, androgen ablation and cryotherapy.  Watchful waiting or surveillance alone is an option for older patients with low-grade or low-stage disease.  -- 2002","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Carcinoma","conceptCode":"C4863","definition":"One of the most common malignant tumors afflicting men.  The majority of carcinomas arise in the peripheral zone and a minority occur in the central or the transitional zone of the prostate gland.  Grossly, prostatic carcinomas appear as ill-defined yellow areas of discoloration in the prostate gland lobes.  Adenocarcinomas represent the overwhelming majority of prostatic carcinomas.  Prostatic-specific antigen (PSA) serum test is widely used as a screening test for the early detection of prostatic carcinoma.  Treatment options include radical prostatectomy, radiation therapy, androgen ablation and cryotherapy.  Watchful waiting or surveillance alone is an option for older patients with low-grade or low-stage disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2962D840-ED32-4EC3-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-02-13","endDate":null,"createdBy":"ALAIS","dateCreated":"2007-02-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"293DFDC3-001F-E19D-E050-BB89AD434F37","beginDate":"2012-01-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-01-13","modifiedBy":"ONEDATA","dateModified":"2016-01-13","deletedIndicator":"No"},{"value":"Surgical Complications","valueDescription":"Surgical Procedure Complication","ValueMeaning":{"publicId":"3452253","version":"1","preferredName":"Surgical Procedure Complication","longName":"3452253","preferredDefinition":"A diagnostic or treatment procedure performed by manual and/or instrumental means, often involving an incision and the removal or replacement of a diseased organ or tissue; of or relating to or involving or used in surgery or requiring or amenable to treatment by surgery.: Complication; any disease or disorder that occurs during the course of (or because of) another disease.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Surgical Procedure","conceptCode":"C15329","definition":"A diagnostic or treatment procedure performed by manual and/or instrumental means, often involving an incision and the removal or replacement of a diseased organ or tissue; of or relating to or involving or used in surgery or requiring or amenable to treatment by surgery.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Complication","conceptCode":"C2959","definition":"Any disease or disorder that occurs during the course of, or because of, another disease, treatment, or procedure.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF785210-5174-5C58-E040-BB89AD432178","latestVersionIndicator":"Yes","beginDate":"2012-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"293DFDC3-0029-E19D-E050-BB89AD434F37","beginDate":"2012-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-01-13","modifiedBy":"ONEDATA","dateModified":"2016-01-13","deletedIndicator":"No"},{"value":"Pancreatic Cancer","valueDescription":"Pancreatic Carcinoma","ValueMeaning":{"publicId":"2672905","version":"1","preferredName":"Pancreatic Carcinoma","longName":"2672905","preferredDefinition":"A carcinoma arising from the exocrine pancreas. The overwhelming majority of pancreatic carcinomas are adenocarcinomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pancreatic Carcinoma","conceptCode":"C3850","definition":"A carcinoma arising from the exocrine pancreas. The overwhelming majority of pancreatic carcinomas are adenocarcinomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"37D5FE1C-A62B-09FD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-08-16","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-08-16","modifiedBy":"COOPERM","dateModified":"2019-04-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"293DFDC3-0033-E19D-E050-BB89AD434F37","beginDate":"2012-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-01-13","modifiedBy":"ONEDATA","dateModified":"2016-01-13","deletedIndicator":"No"},{"value":"Non-Cancer Related","valueDescription":"Negation Malignant Neoplasm Relationship","ValueMeaning":{"publicId":"3624729","version":"1","preferredName":"Negation Malignant Neoplasm Relationship","longName":"3624729","preferredDefinition":"An operation in which a term denies or inverts the meaning of another term or construction.: A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.: A state of connectedness between people, objects, or events; to be associated or connected with something.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Relationship","conceptCode":"C25648","definition":"A state of connectedness between people, objects, or events; to be associated or connected with something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CD842F3B-5BB5-C83A-E040-BB89AD437BB8","latestVersionIndicator":"Yes","beginDate":"2012-11-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-11-02","modifiedBy":"COOPERM","dateModified":"2019-03-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"293DFDC3-003D-E19D-E050-BB89AD434F37","beginDate":"2012-11-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-01-13","modifiedBy":"ONEDATA","dateModified":"2016-01-13","deletedIndicator":"No"},{"value":"Related to Another Cancer","valueDescription":"Other Malignant Neoplasm Relationship","ValueMeaning":{"publicId":"3624730","version":"1","preferredName":"Other Malignant Neoplasm Relationship","longName":"3624730","preferredDefinition":"Different than the one(s) previously specified or mentioned.: A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004: Related; connected or associated.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Relationship","conceptCode":"C25648","definition":"A state of connectedness between people, objects, or events; to be associated or connected with something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CD842F3B-5BDC-C83A-E040-BB89AD437BB8","latestVersionIndicator":"Yes","beginDate":"2012-11-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-11-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"293DFDC3-0047-E19D-E050-BB89AD434F37","beginDate":"2012-11-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-01-13","modifiedBy":"ONEDATA","dateModified":"2016-01-13","deletedIndicator":"No"},{"value":"Related to Head & Neck Cancer","valueDescription":"Head and Neck Carcinoma","ValueMeaning":{"publicId":"3210702","version":"1","preferredName":"Head and Neck Carcinoma","longName":"3210702","preferredDefinition":"A carcinoma of any tissue within the head and neck region.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Head and Neck Carcinoma","conceptCode":"C35850","definition":"A carcinoma that arises from the head and neck region.  Representative examples include oral cavity squamous cell carcinoma, laryngeal squamous cell carcinoma, and salivary gland carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-90E0-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"293DFDC3-0051-E19D-E050-BB89AD434F37","beginDate":"2012-11-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-01-13","modifiedBy":"ONEDATA","dateModified":"2016-01-13","deletedIndicator":"No"},{"value":"Cancer related","valueDescription":"Cancer Related","ValueMeaning":{"publicId":"3628759","version":"1","preferredName":"Cancer Related","longName":"3628759","preferredDefinition":"Related; connected or associated.: A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Relationship","conceptCode":"C25648","definition":"A state of connectedness between people, objects, or events; to be associated or connected with something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CEDDB0E9-AB7A-273E-E040-BB89AD430E35","latestVersionIndicator":"Yes","beginDate":"2012-11-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-11-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"293DFDC3-005B-E19D-E050-BB89AD434F37","beginDate":"2012-11-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-01-13","modifiedBy":"ONEDATA","dateModified":"2016-01-13","deletedIndicator":"No"},{"value":"Testicular Germ Cell Tumor (TGCT)","valueDescription":"Testicular Germ Cell Tumor","ValueMeaning":{"publicId":"3326335","version":"1","preferredName":"Testicular Germ Cell Tumor","longName":"3326335","preferredDefinition":"A germ cell tumor arising from the testis.  Representative examples include teratoma, seminoma, embryonal carcinoma, and yolk sac tumor.\r\n","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Testicular Germ Cell Tumor","conceptCode":"C8591","definition":"A germ cell tumor arising from the testis. Representative examples include teratoma, seminoma, embryonal carcinoma, and yolk sac tumor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B3862B52-B6FE-375A-E040-BB89AD436460","latestVersionIndicator":"Yes","beginDate":"2011-12-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-12-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"293DFDC3-0065-E19D-E050-BB89AD434F37","beginDate":"2014-05-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-01-13","modifiedBy":"ONEDATA","dateModified":"2016-01-13","deletedIndicator":"No"},{"value":"Death not Caused by Disease","valueDescription":"Not Caused by Disease","ValueMeaning":{"publicId":"5037551","version":"1","preferredName":"Not Caused by Disease","longName":"5037551","preferredDefinition":"An operation in which a term denies or inverts the meaning of another term or construction.: The cause of a disease.: Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Etiology","conceptCode":"C16390","definition":"The cause of a disease or abnormal condition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"22A4EFEF-16AD-5805-E050-BB89AD43048F","latestVersionIndicator":"Yes","beginDate":"2015-10-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-10-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"293DFDC3-006F-E19D-E050-BB89AD434F37","beginDate":"2015-10-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-01-13","modifiedBy":"ONEDATA","dateModified":"2016-01-13","deletedIndicator":"No"},{"value":"Metastatic Uveal Melanoma","valueDescription":"Metastatic Uveal Melanoma","ValueMeaning":{"publicId":"5037552","version":"1","preferredName":"Metastatic Uveal Melanoma","longName":"5037552","preferredDefinition":"A term referring to the clinical or pathologic observation of a tumor extension from its original site of growth to another anatomic site.: A melanoma derived from melanocytes of the uveal tract.  It is the most common primary intraocular tumor in the United States and Western Europe.  Similar to melanoma of the skin, it is rare in Africa and Asia.  Diagnostic procedures include ophthalmoscopic exam, fluorescein angiography and ultrasound.  Treatment includes: surgical excision of the eye, iridocyclectomy and tumor resection.  Recent treatments also include radiotherapy or photo coagulation.  Classification of uveal melanomas recognizes four cell types within these tumors: epithelioid, intermediate, mixed cell, and spindle cell types.  The spindle cell type uveal melanomas are further sub-classified as spindle cell type A and spindle cell type B.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Metastatic","conceptCode":"C14174","definition":"A term referring to the clinical or pathologic observation of a tumor extension from its original site of growth to another anatomic site.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Uveal Melanoma","conceptCode":"C7712","definition":"A melanoma derived from melanocytes of the uveal tract.  It is the most common primary intraocular tumor in the United States and Western Europe.  Similar to melanoma of the skin, it is rare in Africa and Asia.  Diagnostic procedures include ophthalmoscopic exam, fluorescein angiography and ultrasound.  Treatment includes: surgical excision of the eye, iridocyclectomy and tumor resection.  Recent treatments also include radiotherapy or photo coagulation.  Classification of uveal melanomas recognizes four cell types within these tumors: epithelioid, intermediate, mixed cell, and spindle cell types.  The spindle cell type uveal melanomas are further sub-classified as spindle cell type A and spindle cell type B.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"22A4EFEF-16D3-5805-E050-BB89AD43048F","latestVersionIndicator":"Yes","beginDate":"2015-10-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-10-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"293DFDC3-0079-E19D-E050-BB89AD434F37","beginDate":"2015-10-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-01-13","modifiedBy":"ONEDATA","dateModified":"2016-01-13","deletedIndicator":"No"},{"value":"Submitted malignancy and/or related tumor event","valueDescription":"Malignancy or Related Tumor Event","ValueMeaning":{"publicId":"5102233","version":"1","preferredName":"Malignancy or Related Tumor Event","longName":"5102233","preferredDefinition":"A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: A state of connectedness between people, objects, or events; to be associated or connected with something.: A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.: Something that happens at a given place and time.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Relationship","conceptCode":"C25648","definition":"A state of connectedness between people, objects, or events; to be associated or connected with something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Event","conceptCode":"C25499","definition":"Something that happens at a given place and time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"293DFDC3-0091-E19D-E050-BB89AD434F37","latestVersionIndicator":"Yes","beginDate":"2016-01-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-01-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"293DFDC3-00AA-E19D-E050-BB89AD434F37","beginDate":"2016-01-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-01-13","modifiedBy":"ONEDATA","dateModified":"2016-01-13","deletedIndicator":"No"},{"value":"Related to this cancer","valueDescription":"Related to This Cancer","ValueMeaning":{"publicId":"6134038","version":"1","preferredName":"Related to This Cancer","longName":"6134038","preferredDefinition":"A state of connectedness between people, objects, or events; to be associated or connected with something.: Occurring in or belonging to the present time.: A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Relationship","conceptCode":"C25648","definition":"A state of connectedness between people, objects, or events; to be associated or connected with something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Current","conceptCode":"C25471","definition":"Occurring in or belonging to the present time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"67753717-206F-24AD-E053-F662850AE027","latestVersionIndicator":"Yes","beginDate":"2018-03-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-15","modifiedBy":"COOPERM","dateModified":"2018-03-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"67753717-2088-24AD-E053-F662850AE027","beginDate":"2018-03-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-15","modifiedBy":"ONEDATA","dateModified":"2018-03-15","deletedIndicator":"No"},{"value":"Not Reported","valueDescription":"Not Reported","ValueMeaning":{"publicId":"2572578","version":"1","preferredName":"Not Reported","longName":"2572578","preferredDefinition":"Not provided or available.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Reported","conceptCode":"C43234","definition":"Not provided or available.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E88F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-12-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-12-30","modifiedBy":"DWARZEL","dateModified":"2018-03-26","changeDescription":"03/09/2011 - tc - Updated with concept code.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"835934C2-FA6D-5520-E053-F662850AB1A0","beginDate":"2019-03-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-03-05","modifiedBy":"ONEDATA","dateModified":"2019-03-05","deletedIndicator":"No"},{"value":"Toxicity","valueDescription":"Toxicity","ValueMeaning":{"publicId":"4615972","version":"1","preferredName":"Toxicity","longName":"4615972","preferredDefinition":"The finding of bodily harm due to the poisonous effects of something.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Toxicity","conceptCode":"C27990","definition":"The finding of bodily harm due to the poisonous effects of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"09172D7F-C118-E939-E050-BB89AD434D48","latestVersionIndicator":"Yes","beginDate":"2014-11-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-11-30","modifiedBy":"ONEDATA","dateModified":"2014-11-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"835934C2-FA78-5520-E053-F662850AB1A0","beginDate":"2019-03-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-03-05","modifiedBy":"ONEDATA","dateModified":"2019-03-05","deletedIndicator":"No"},{"value":"Spinal Muscular Atrophy","valueDescription":"Spinal Muscular Atrophy","ValueMeaning":{"publicId":"3211451","version":"1","preferredName":"Spinal Muscular Atrophy","longName":"3211451","preferredDefinition":"An inherited disorder characterized by degeneration of the spinal cord and the cerebellum. Symptoms may appear at any age and include progressive loss of coordination of gait, hands, speech, and eye movements.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Spinal Muscular Atrophy","conceptCode":"C85075","definition":"An inherited disorder characterized by degeneration of the spinal cord and the cerebellum. Symptoms may appear at any age and include progressive loss of coordination of gait, hands, speech, and eye movements.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-FFB7-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"835934C2-FA82-5520-E053-F662850AB1A0","beginDate":"2019-03-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-03-05","modifiedBy":"ONEDATA","dateModified":"2019-03-05","deletedIndicator":"No"},{"value":"Renal Disorder, NOS","valueDescription":"Renal Disorder, NOS","ValueMeaning":{"publicId":"6661291","version":"1","preferredName":"Renal Disorder, NOS","longName":"6661291","preferredDefinition":"Not characterized in any other way.: A neoplastic or non-neoplastic condition affecting the kidney. Representative examples of non-neoplastic conditions include glomerulonephritis and nephrotic syndrome. Representative examples of neoplastic conditions include benign processes (e.g., renal lipoma and renal fibroma) and malignant processes (e.g., renal cell carcinoma and renal lymphoma).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Kidney Disorder","conceptCode":"C3149","definition":"A neoplastic or non-neoplastic condition affecting the kidney. Representative examples of non-neoplastic conditions include glomerulonephritis and nephrotic syndrome. Representative examples of neoplastic conditions include benign processes (e.g., renal lipoma and renal fibroma) and malignant processes (e.g., renal cell carcinoma and renal lymphoma).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"835934C2-FA90-5520-E053-F662850AB1A0","latestVersionIndicator":"Yes","beginDate":"2019-03-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-03-05","modifiedBy":"COOPERM","dateModified":"2019-03-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"835934C2-FAA9-5520-E053-F662850AB1A0","beginDate":"2019-03-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-03-05","modifiedBy":"ONEDATA","dateModified":"2019-03-05","deletedIndicator":"No"},{"value":"Infection","valueDescription":"Infection","ValueMeaning":{"publicId":"6610519","version":"1","preferredName":"Infection","longName":"6610519","preferredDefinition":"The invasion of an organism's body tissues by disease-causing agents and their multiplication, as well as the reaction by the host to these organisms and/or toxins that the organisms produce.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Infection","conceptCode":"C128320","definition":"The invasion of an organism's body tissues by disease-causing agents and their multiplication, as well as the reaction by the host to these organisms and/or toxins that the organisms produce.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7F7FD6EF-C887-4DB3-E053-F662850AB340","latestVersionIndicator":"Yes","beginDate":"2019-01-15","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-01-15","modifiedBy":"ONEDATA","dateModified":"2019-01-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"835934C2-FAB3-5520-E053-F662850AB1A0","beginDate":"2019-03-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-03-05","modifiedBy":"ONEDATA","dateModified":"2019-03-05","deletedIndicator":"No"},{"value":"End-stage Renal Disease","valueDescription":"Chronic Kidney Disease, Stage 5","ValueMeaning":{"publicId":"4395774","version":"1","preferredName":"Chronic Kidney Disease, Stage 5","longName":"4395774","preferredDefinition":"Long-standing and persistent renal disease with glomerular filtration rate (GFR) less than 15 ml/min.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chronic Kidney Disease, Stage 5","conceptCode":"C9439","definition":"Long-standing and persistent renal disease with glomerular filtration rate (GFR) less than 15 ml/min.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FEB8F754-D9B5-8D06-E040-BB89AD437F49","latestVersionIndicator":"Yes","beginDate":"2014-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-21","modifiedBy":"COOPERM","dateModified":"2019-03-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"835934C2-FAC8-5520-E053-F662850AB1A0","beginDate":"2019-03-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-03-05","modifiedBy":"ONEDATA","dateModified":"2019-03-05","deletedIndicator":"No"},{"value":"Cardiovascular Disorder, NOS","valueDescription":"Cardiovascular Disorder, NOS","ValueMeaning":{"publicId":"6661292","version":"1","preferredName":"Cardiovascular Disorder, NOS","longName":"6661292","preferredDefinition":"Not characterized in any other way.: A non-neoplastic or neoplastic disorder affecting the heart or the vessels (arteries, veins and lymph vessels). Representative examples of non-neoplastic cardiovascular disorders are endocarditis and hypertension. Representative examples of neoplastic cardiovascular disorders are endocardial myxoma and angiosarcoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Cardiovascular Disorder","conceptCode":"C2931","definition":"A non-neoplastic or neoplastic disorder affecting the heart or the vessels (arteries, veins and lymph vessels). Representative examples of non-neoplastic cardiovascular disorders are endocarditis and hypertension. Representative examples of neoplastic cardiovascular disorders are endocardial myxoma and angiosarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"835934C2-FAD6-5520-E053-F662850AB1A0","latestVersionIndicator":"Yes","beginDate":"2019-03-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-03-05","modifiedBy":"COOPERM","dateModified":"2019-03-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"835934C2-FAEF-5520-E053-F662850AB1A0","beginDate":"2019-03-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-03-05","modifiedBy":"ONEDATA","dateModified":"2019-03-05","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008554","version":"1","preferredName":"Treatment/Off-treatment Reasons","preferredDefinition":"justification for or explanation of the administration or cessation of therapy.","longName":"TX_OTX_RSNS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2C9BE32-8BDB-649C-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2240632","version":"1","preferredName":"Reason","preferredDefinition":"An explanation of the cause of some phenomenon or action.","longName":"C25638","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Reason","conceptCode":"C25638","definition":"An explanation of the cause of some phenomenon or action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F9FA7953-8391-043D-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-30","endDate":null,"createdBy":"PWEST","dateCreated":"2005-06-30","modifiedBy":"ONEDATA","dateModified":"2005-06-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"293DFDC2-FFB0-E19D-E050-BB89AD434F37","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-01-13","modifiedBy":"COOPERM","dateModified":"2019-03-05","changeDescription":"ISO 11179 compliance.  PV added for The Cancer Genome Atlas (TCGA) by request of S. Ratliff (JP) 3/2011. Added 2 PVs per TCGA request by B.McClure-Shimel. mc 5/7/12 Versioned to remove CASP1 Gene concept from rep term qualifier. mc 10/23/15 Versioned to extend max length and add 1 PV. mc 1/13/2016; Added 7 PVs for GDC. mc 3.5.19","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2812367","version":"1","longName":"caBIG","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]},{"publicId":"2183535","version":"1","longName":"Clinical Trial Mgmt Systems","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812724","version":"1","longName":"Duke U New CDEs","context":"NCIP"},{"publicId":"2812625","version":"1","longName":"CTMS C3D Adopter Sites","context":"NCIP"},{"publicId":"2811715","version":"1","longName":"Duke University","context":"NCIP"},{"publicId":"2812723","version":"1","longName":"ThermoDox Study","context":"NCIP"}]},{"publicId":"2756809","version":"1","longName":"TCGA (The Cancer Genome Atlas)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6044923","version":"1","longName":"Active CDEs as of March 2017","context":"NCIP"}]},{"publicId":"3787498","version":"1","longName":"TCGA 2.6 by Disease","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3787505","version":"1","longName":"HNSC","context":"NCIP"},{"publicId":"3787508","version":"1","longName":"KIRP","context":"NCIP"},{"publicId":"3787513","version":"1","longName":"LUSC","context":"NCIP"},{"publicId":"3787514","version":"1","longName":"OV","context":"NCIP"},{"publicId":"3787516","version":"1","longName":"PRAD","context":"NCIP"},{"publicId":"3787502","version":"1","longName":"CESC","context":"NCIP"},{"publicId":"3787503","version":"1","longName":"COAD","context":"NCIP"},{"publicId":"3787504","version":"1","longName":"GBM","context":"NCIP"},{"publicId":"3787506","version":"1","longName":"KICH","context":"NCIP"},{"publicId":"3787507","version":"1","longName":"KIRC","context":"NCIP"},{"publicId":"3787499","version":"1","longName":"BLCA","context":"NCIP"},{"publicId":"3787500","version":"1","longName":"BRCA","context":"NCIP"},{"publicId":"3787510","version":"1","longName":"LGG","context":"NCIP"},{"publicId":"3787509","version":"1","longName":"LAML","context":"NCIP"},{"publicId":"3787511","version":"1","longName":"LIHC","context":"NCIP"},{"publicId":"3787519","version":"1","longName":"SKCM","context":"NCIP"},{"publicId":"3787512","version":"1","longName":"LUAD","context":"NCIP"},{"publicId":"3787517","version":"1","longName":"READ","context":"NCIP"},{"publicId":"3787518","version":"1","longName":"SARC","context":"NCIP"},{"publicId":"3787520","version":"1","longName":"STAD","context":"NCIP"},{"publicId":"3787522","version":"1","longName":"UCEC","context":"NCIP"},{"publicId":"3787521","version":"1","longName":"THCA","context":"NCIP"},{"publicId":"3787515","version":"1","longName":"PAAD","context":"NCIP"}]},{"publicId":"3886752","version":"1","longName":"For Review","context":"DCI","ClassificationSchemeItems":[{"publicId":"3891931","version":"1","longName":"For Review","context":"DCI"}]},{"publicId":"5428034","version":"1","longName":"Clinical","context":"GDC","ClassificationSchemeItems":[{"publicId":"2812234","version":"1","longName":"Demographic","context":"GDC"}]}],"AlternateNames":[{"name":"Patient Death Reason","type":"TCGA_Name","context":"NCIP"},{"name":"patient_death_reason","type":"TCGA_XML_Name","context":"NCIP"},{"name":"OCG","type":"USED_BY","context":"OCG"},{"name":"GDC","type":"USED_BY","context":"GDC"},{"name":"cause_of_death","type":"GDC_Name","context":"GDC"}],"ReferenceDocuments":[{"name":"Cause of death (check only on","type":"Preferred Question Text","description":"Cause of death (check only one)","url":null,"context":"NCIP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"293DFDC3-00C9-E19D-E050-BB89AD434F37","latestVersionIndicator":"Yes","beginDate":"2016-01-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-01-13","modifiedBy":"COOPERM","dateModified":"2019-03-06","changeDescription":"Curated to support Duke University adoption of C3D for ThermoDox trial. 10/23/15 mc Versioned to remove rep term qualifier concept CAPS1 gene. 1/13/2016 Versioned to extend VD max length. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}